Drug that was tested for use against Ebola could treat COVID-19
The results of the study will be announced by May 1 this year.
A US biotech company said it is working with Chinese authorities to determine if the antiviral drug remdesivir can provide effective treatment for patients infected with the rapidly spreading coronavirus known as COVID-19..
The company hopes to find out by May 1st..
Gilead Sciences, a biopharmaceutical company that developed the drug remdesivir as a treatment for Ebola and another disease, told Voice of America that the company has already begun two clinical trials in infected patients “to determine the safety and efficacy of remdesivir as a potential drug. treatment of coronavirus “.
Information about testing was welcomed in China. Concerned about the outbreak of coronavirus, Chinese residents say that the four syllables “remdesivir” sound like a phrase in Chinese: “people’s hope”.
News Service &# 171; Voices of america&# 187;
Eli Lilly CEO explains the supply chain of Covid-19 antibody drug Government to purchase 300,000 doses of an experimental antibody drug The US government…
Eli Lilly reports results from Covid-19 phase 2 antibody drug trial Tests have shown that the antibody-based drug reduces the need for hospitalization in…
Protesters should be tested for COVID-19: CDC director Centers for Disease Control and Prevention (CDC) Chief Suggests Mass Protests May Foster New…
In the absence of a vaccine, treatment of COVID-19 with antibodies is considered a promising technique WASHINGTON – Doctors are trying to grow the human…
CORONAVIRUS EFFECT ON YOUR EYE | What to Know About COVID-19 / SARS-CoV-2 From an Ophthalmologist The American Academy of Ophthalmology asks…